It?s not only the Australia and New Zealand Banking Group (ASX: ANZ) share price climbing to a new 52-week high today, several shares have also followed suit with solid gains.
Three which have caught my eye are listed below. Here?s why they have hit new 52-week highs:
The Australian Pharmaceutical Industries Ltd (ASX: API) share price reached a 52-week high of $2.20 this morning. Investors have been fighting to get hold of the Priceline operator?s shares since it announced a 15% increase in underlying net profit after tax last week. Despite trading at a 52-week high, I think its shares…
To keep reading, enter your email address or login below.
Three which have caught my eye are listed below. Here’s why they have hit new 52-week highs:
The Australian Pharmaceutical Industries Ltd (ASX: API) share price reached a 52-week high of $2.20 this morning. Investors have been fighting to get hold of the Priceline operator’s shares since it announced a 15% increase in underlying net profit after tax last week. Despite trading at a 52-week high, I think its shares are great value for money at just over 18x trailing earnings.
The BT Investment Management Ltd (ASX: BTT) share price climbed to a 52-week high of $11.91 this morning and is now closing in on its all-time high. Although many investors expected the Brexit to negatively impact the fund manager, the company has gone from strength to strength despite the currency headwinds. Thanks to large in-flows from its JO Hambro business, BTIM recently reported a 4.8% increase in funds under management.
The Qantas Airways Limited (ASX: QAN) share price has hit a new 52-week high of $4.16 today. Incredibly this latest gain means the leading airline has now seen its shares rise by a remarkable 24% so far this year. A combination of broker upgrades and falling oil prices are likely to be the reason behind the strong gain. Whilst it’s shares are getting a little expensive now, I still believe Qantas could fly higher if oil prices stay low.
Here are three more shares which I think are on their way to new 52-week highs. Grab them whilst you can!
For many, blue chip stocks means stability, profitability and regular dividends, often fully franked..
But knowing which blue chips to buy, and when, can be fraught with danger.
The Motley Fool's in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool's Top 3 Blue Chip Stocks for 2017."
Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.
If you're expecting to see the likes of Commonwealth Bank, Telstra and Wesfarmers shares on this list, you'll be sorely disappointed. Not only are their dividends growing at a snail's pace, their profits are under pressure too due to the increasing competitive environment.
The contrast to these "new breed" blue chips couldn't be greater... especially the very real prospect of significant share price gains, something that's looking less likely from the usual blue chip suspects.
The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand - and how quickly the share prices of these companies moves - we may be forced to remove this report.
Click here to claim your free report.
Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.